REFERENCES
- Yoshimi A, Kojima S, Hirano N. Juvenile myelomonocytic leukemia:
epidemiology, etiopathogenesis, diagnosis, and management
considerations. Pediatr Drugs 2010;12:11-21.
- Tefferi A, Vardiman JW. Classification and diagnosis of
myeloproliferative neoplasms: the 2008 World Health Organization
Criteria and point-of-care diagnostic algorithms. Leukemia
2008;22:14-22.
- Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic
leukemia: a report from the 2nd international JMML
symposium. Leuk Res 2009;33:355-62.
- Yoshida N, Hirabayashi S, Watanabe S, et al. Prognosis of 75 patients
with juvenile myelomonocytic leukemia: prospective study by MDS
committee in the Japanese Society of Pediatric Hematology. Rinsho
Ketshueki 2011;52:1853-8.
- Niemeyer CM, Arico M, Basso G, et al. Chronic myelomonocytic leukemia
in childhood: a retrospective analysis of 110 cases. European Working
Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood
1997;89:3534-43.
- Sakashita K, Matsuda K, Koike K. Diagnosis and treatment of juvenile
myelomonocytic leukemia. Pediatrics International 2016;58:681-90.
- Yabe M, Ohtsuka Y, Watanabe K, Inagaki J, Yoshida N, Sakashita K, et
al. Transplantation for juvenile myelomonocytic leukemia: a
retrospective study of 30 children treated with a regimen of busulfan,
fludarabine, and melphalan. Int J Hematol 2015;101:184–90.
- Dvorak CC, Loh ML. Juvenile myelomonocytic leukemia: molecular
pathogenesis informs current approaches to therapy and hematopoietic
cell transplantation. Front Pediatr 2014;25.eCollection.
- Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et
al. The 2016 revision to the World Healt Organization classification
of myeloid neoplasms and acute leukemia. Blood 2016;127:2391-2405.
- Locatelli F, Algeri M, Merli P, Strocchio L. Novel approaches to
diagnosis and treatment of juvenile myelomonocytic leukemia. Expert
Rev Hematol 2018;11:129-43.
- Locatelli F, Nolke P, Zecca M, Korthof E, Lanino E, Peters C, et al.
Hematopoietic stem cell transplantation (HSCT) in children with
juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT
trial. Blood 2005;105:410-19.
- Honda Y, Tsuchida M, Zaike Y, Masunaga A, Yoshimi A, Kojima S, et al.
Clinical characteristics of 15 children with juvenile myelomonocytic
leukaemia who developed blast crisis: MDS Committee of Japanese
Society of Paediatric Haematology/Oncology. Br J Haematol
2014;165:682–7.
- Gupta DK, Meena JP, Chopra A, Tanwar P, Seth R. Juvenile
myelomonocytic leukemia-a comprehensive review and recent advances in
management. Am J Blood Res 2021;11:1-21.
- Bergstraesser E, Hasle H, Rogge T, Fischer A, Zimmerman M, et al.
Non-hematopoietic stem cell transplantation treatment of juvenile
myelomonocytic leukemia: a retrospective analysis and definition of
response criteria. Pediatr Blood Cancer 2007;49:629–33. https://doi.
org/10.1002/pbc.21038.
- Niemeyer CM, Kratz C. Juvenile myelomonocytic leukemia. Curr Oncol Rep
2003;5:510–15.
- Sakashita K, Matsuda K, Koike K. Diagnosis and treatment of juvenile
myelomonocytic leukemia. Pediatr Int 2016;58:681–90.
- Jin Kang H, Young Sin H, Soo Choi H, Seop Ahn H. Novel regimen for the
treatment of juvenile myelomonocytic leukemia (JMML). Leukemia
Research 2004;28:167-70.
- Feng X, Peng Z, He Y, Li C, Ruang Y, Liu X, et al. Improvement of
survival in JMMLl by induction regimen of decitabine + cytarabine +
fludarabine before hematopoietic stem cell transplantation: study of
33 cases in single center. Blood 2019;134(suppl):4267.
- Cseh A, Niemeyer CM, Yoshimi A, Dworzak M, Hasle H, van den
Heuvel-Eibrink MM, et al. Bridging to transplant with azacitidine in
juvenile myelomonocytic leukemia: a retrospective analysis of the
EWOG-MDS study group. Blood 2015;125:2311–3.
- Leoncini PP, Vitullo P, Di Florio F, Tocco V, Cefalo MG, Pitisci A, et
al. Whole Genome MBD-seq reveals different CpG methylation patterns in
Azacytidine-treated juvenile myelomonocytic leukemia (JMML) patients.
Br J Haematol 2018;182:909-12.
- Fabri O, Horakova J, Bodova I, Svec P, LaluhovaStriezencova Z, et al.
Diagnosis and treatment of juvenile myelo-monocytic leukemia in the
Slovak Republic: novel approaches. Neoplasma 2019;66:818- 24.
- World Health Organization. Definitions of palliative care. Geneva;
2002; 2017.
- Committee on Hospital Care and Institute for Patient-and
Family-Centered Care. Patient-and-family centered care and the
pediatrician’s role. Pediatrics 2012;129: 394-404.
- Feudtner C, Friebert S, Jewell J, Carter B, Hood M, Imaizumi S, et al.
Pediatric palliative care and hospice care commitments, guidelines,
and recommendations. Pediatrics 2013;132:966-72.
- Doherty M, Thabet C. Development and implementation of a pediatric
palliative care program in a developing country. Frontiers Pub Health
2018;6: doi: 10.3389/fpubh.2018.00106.